ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate Director, Competitive Intelligence at Neurocrine Biosciences - ApplyBlast

Associate Director, Competitive Intelligence

Neurocrine Biosciences

28 days ago

3.7 on Glassdoor

San Diego, California, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Associate Director, Competitive Intelligence will advance Neurocrine's competitive intelligence capabilities across its commercial portfolio, clinical pipeline, and research programs. This role involves providing strategic insights and recommendations to senior leaders by translating complex scientific, clinical, and commercial information into actionable business strategies. The position also focuses on leveraging modern AI tools to enhance the collection, analysis, and dissemination of competitive intelligence.

Responsibilities

Develop competitive landscapes and strategic insights across therapeutic areas
Lead competitive assessments around major clinical and regulatory catalysts
Champion AI-enabled tools to synthesize scientific and market information

Skills

Qualifications

BS/BA degree in life sciences, business or related disciplineMaster's/MBAPhD/PharmD/MD or other advanced degree

About Neurocrine Biosciences

neurocrine.com

Headquarters

San Diego, California, United States

Company Size

1001-5000 employees

Founded

1992

View Profile

Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.